Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Sep 28:10.1158/1055-9965.EPI-21-0644. doi: 10.1158/1055-9965.EPI-21-0644

Table 3b:

Concordance between self-reported and clinically ascertained peripheral neuropathy among males (N=1,497)

Self-Report symptoms Sensitivity Specificity Accuracy Kappa

Clinically ascertained PSN (N=63)

Yes No

Decreased sense of touch or feeling in hands, fingers, arms, or legs, (N) Yes 15 109 24.6% 92.3% 89.5% 0.113

No 46 1306

Prolonged pain in arms, legs, or back, (N) Yes 27 234 44.3% 83.4% 81.8% 0.108

No 34 1178

Abnormal sensation in arms, legs, or back, (N) Yes 15 125 25.4% 91.1% 88.5% 0.100

No 44 1286

≥2 of 5 symptoms, (N) Yes 20 157 32.8% 89.0% 86.7% 0.114

No 41 1270

Clinically ascertained PMN (N=84)

Weakness or inability to move arm(s), (N) Yes 19 31 23.8% 97.8% 93.8% 0.261

No 61 1361

Weakness or inability to move legs, (N) Yes 28 45 35.4% 96.8% 93.5% 0.334

No 51 1348

≥2 of 5 symptoms, (N) Yes 40 137 48.2% 90.2% 87.9% 0.251

No 43 1268

Both PSN and PMN1 (N=23)

Decreased sense of touch or feeling in hands, fingers, arms, or legs, (N) Yes 11 113 47.8% 92.2% 91.5% 0.127

No 12 1340

Prolonged pain in arms, legs, or back, (N) Yes 12 249 40.0% 92.3% 91.8% 0.058

No 11 1201

Abnormal sensation in arms, legs, or back, (N) Yes 9 131 42.9% 91.0% 90.3% 0.089

No 12 1318

Weakness or inability to move arm(s), (N) Yes 7 43 31.8% 97.0% 96.1% 0.177

No 15 1407

Weakness or inability to move legs, (N) Yes 11 62 52.4% 95.7% 95.1% 0.217

No 10 1389

≥2 of 5 symptoms, (N) Yes 13 164 56.5% 88.9% 88.3% 0.105

No 10 1301

Either PSN or PMN2 (N=124)

Decreased sense of touch or feeling in hands, fingers, arms, or legs, (N) Yes 38 86 31.4% 93.7% 88.6% 0.248

No 83 1269

Prolonged pain in arms, legs, or back, (N) Yes 55 206 45.8% 84.8% 81.6% 0.199

No 65 1147

Abnormal sensation in arms, legs, or back, (N) Yes 32 108 27.1% 92.0% 86.8% 0.176

No 86 1244

Weakness or inability to move arm(s), (N) Yes 19 31 16.1% 97.7% 91.2% 0.187

No 99 1323

Weakness or inability to move legs, (N) Yes 33 40 28.2% 97.0% 91.6% 0.305

No 84 1315

≥2 of 5 symptoms, (N) Yes 47 130 38.8% 90.5% 86.3% 0.242

No 74 1237
1

Both PSN and PMN: Individuals with clinically ascertained both PSN and PMN.

2

Either PSN or PMN: Individuals with clinically ascertained either PSN or PMN.

≥: more than or equal to; %: percent; N: number; PMN: Clinically ascertained peripheral motor neuropathy; PSN: Clinically ascertained peripheral sensory neuropathy